With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|Immunotherapy for Osteosarcoma and Ewing sarcoma||Baylor College of Medicine / Nabil Ahmed, MD, MSc||Young Investigator Grants||2007||Texas|
|High-throughput CAR NKT Library Screen for Improving Neuroblastoma Immunotherapy||Baylor College of Medicine / Xavier Rios, MD/PhD||Young Investigator Grants||2020||Texas|
|Critical Contributions of CRM1 to Leukemogenesis||University of Vermont / Jessica Linda Heath, MD||Young Investigator Grants||2015||Vermont|
|Identification and Validation of Differentiation Therapy for Osteosarcoma||Dana-Farber Cancer Institute / Katherine Janeway, MD||Young Investigator Grants||2008||Massachusetts|
|The Role of DNA Methylation in Pediatric Cancer||Fred Hutchinson Cancer Research Center / Scott Diede||Young Investigator Grants||2010||Washington|
|Targeting Eya2 to Inhibit c-Myc driven Medulloblastoma Tumor Progression||University of Colorado Denver / Melanie Vincent, PhD||Young Investigator Grants||2016||Colorado|
|Histone Modification and Hmgn1 Overexpression as Drivers of B-ALL with Polysomy 21||Dana-Farber Cancer Institute / Andrew Lane, MD, PhD||Young Investigator Grants||2013||Massachusetts|
|Genetic Regulators of ER Stress-induced Apoptosis in Pediatric Malignancies||Dana-Farber Cancer Institute / Ujwal Pyati||Young Investigator Grants||2009||Massachusetts|
|Aberrant DNA methylation in Ewing sarcoma.||Fred Hutchinson Cancer Research Center / Scott Borinstein||Young Investigator Grants||2009||Washington|
|GPC2 as an Oncogene and Immunotherapeutic Target in High-risk Neuroblastoma||Children's Hospital of Philadelphia / Kristopher Bosse, MD||Young Investigator Grants||2016||Pennsylvania|